4.7 Article

Multiparametric MRI-based VI-RADS: can it predict 1-to 5-year recurrence of bladder cancer?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Review Urology & Nephrology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Marko Babjuk et al.

Summary: The updated EAU guidelines provide new information on the diagnosis and treatment of NMIBC for clinical practice. Individual risk assessment is crucial in determining the appropriate treatment for patients with different risk levels. Surgical intervention, including radical cystectomy, may be necessary for cases unresponsive to BCG treatment or with high risk of progression.

EUROPEAN UROLOGY (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice

Qian Cai et al.

Summary: The study investigates the diagnostic performance and interobserver agreement of the Vesical Imaging Reporting and Data System (VI-RADS) in evaluating muscle invasion for bladder tumors located at the ureteral orifice. The results suggest that VI-RADS has high accuracy in predicting muscle invasion for bladder tumors occurring at the ureteral orifice.

RADIOLOGY (2022)

Article Oncology

Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer

Mateusz Jobczyk et al.

Summary: This study developed a new tool for predicting recurrence and progression of early-stage bladder cancer. By utilizing advanced artificial intelligence, the tool combines state-of-the-art scales and outperforms existing standard assessment tools in terms of predictive performance.

EUROPEAN UROLOGY ONCOLOGY (2022)

Review Urology & Nephrology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

J. Alfred Witjes et al.

Summary: This article presents the updated European Association of Urology guidelines for muscle-invasive and metastatic bladder cancer, providing practical evidence-based recommendations and consensus statements on clinical management. The guidelines cover a broad scope and incorporate the latest research findings and results from consensus meetings.

EUROPEAN UROLOGY (2021)

Article Oncology

Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study

Bas W. G. van Rhijn et al.

Summary: The study compared the prognostic value of WHO1973 and WHO2004/2016 classification systems in non-muscle invasive bladder cancer patients, showing that WHO1973 had a higher predictive value for progression compared to WHO2004/2016, while both systems were not significantly predictive for recurrence. The combined use of both systems can better stratify patients and improve the accuracy of prognosis prediction.

EUROPEAN UROLOGY ONCOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors

Xiaopan Xu et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Detrusor Muscle Invasion

Huanjun Wang et al.

RADIOLOGY (2019)

Editorial Material Urology & Nephrology

Vesical Imaging-Reporting and Data System (VI-RADS): Added Value for Management of Bladder Cancer Patients?

Harriet C. Thoeny et al.

EUROPEAN UROLOGY (2018)

Review Oncology

Modelling bladder cancer in mice: opportunities and challenges

Takashi Kobayashi et al.

NATURE REVIEWS CANCER (2015)